David Gordon, M.D., Dean

Dean of the School of Health Professions and Studies

Office:	2205 WSW
Phone:	810.237.6503
E-mail:	dgordon@umflint.edu
Web Site:	www.umflint.edu/shps/

Areas of Research Interest:

Diversity in Medical Education
Minority Health Research Programs
Human Diagnostic and Experimental Cardiovascular Pathology
Human Atherosclerosis
Cardiovascular and Anatomic Pathology

Teaching Experience:

Academic Appointments:

Mar. 1, 1985- July 1, 1991	Assistant Professor of Pathology, Department of Pathology, University of Washington School of Medicine, Seattle, WA
July 1, 1991- Nov. 15, 1991	Associate Professor of Pathology (with tenure), Department of Pathology, University of Washington School of Medicine, Seattle, WA
Dec. 1, 1991- Nov. 16, 1997	Associate Professor of Pathology, Department of Pathology, University of Michigan School of Medicine, Ann Arbor, MI (Received tenure 1997)
Nov. 16, 1997- Jan. 31, 2001	Adjunct Associate Professor of Pathology, Department of Pathology, University of Michigan School of Medicine, Ann Arbor, MI (Note: during this time I was a research fellow with Pfizer Global Research and Development, Ann Arbor, MI.)>
Feb. 1, 2001- present	Professor of Pathology (with tenure), Dept. of Pathology, Univ. of Michigan School of Medicine, Ann Arbor, MI

Academic Administrative Appointments:

Mar. 1, 1985- Nov. 15, 1991	Director of Autopsy Service, Univ. of Washington, Univ. Hospital
Aug. 1, 1994- Nov. 16, 1997	Assistant Dean for Faculty Affairs, University of Michigan, Ann Arbor, MI.
July 1, 1996- Nov. 16, 1997	Associate Director, Jobst Vascular Research Laboratory, Div. of Vascular Surgery, University of Michigan, Ann Arbor, MI
Feb. 1, 2001- Mar. 31, 2004	Assistant Dean for Diversity and Career Development. University of Michigan, Ann Arbor, MI
April 1, 2004- 2011	Associate Dean for Diversity and Career Development, University of Michigan, Ann Arbor, MI
Aug. 16, 2011- Present	Dean, School of Health Professions and Studies, University of Michigan-Flint, Flint, MI

Information:

Dr. Gordon received a B.A. in Chemistry from Amherst College as well as a M.D. from Harvard Medical School. While at Harvard, he completed a vascular biology research fellowship with Dr. Karnovsky. Afterwards, Dr. Gordon completed an internal medicine internship at the University of Massachusetts (Worcester, MA), before training in anatomic pathology at the University of Washington in Seattle. Later, he joined the faculty at the University of Washington and worked as a human diagnostic and experimental cardiovascular pathologist.

Dr. Gordon was recruited to the University of Michigan in 1991. His clinical interests included the areas of human atherosclerosis biology and gene therapy for vascular diseases. In addition, he served as an Assistant Dean for Faculty Affairs for the Medical School. From 1997 to 2001, Dr. Gordon worked with Pfizer Cardiovascular Therapeutics' pre-clinical division where his group pursued further work on gene therapy for therapeutic angiogenesis. In March of 2001, Dr. Gordon returned to the University of Michigan Medical School to serve as Assistant Dean for Diversity and Career Development, and was concurrently a Professor of Pathology. On April 1, 2004, the university promoted Dr. Gordon to the position of Associate Dean for Diversity and Career Development, which accompanied his service as Professor of Pathology.

As the Associate Dean for Diversity and Career Development, David Gordon oversaw efforts to promote diversity within the Medical School. These efforts particularly focused on faculty and medical student recruitment and development, and on creating a new Minority Health Research Program for the Medical School. Dr. Gordon also worked with the pipeline programs to encourage high school and undergraduate minorities towards the various health professions. He also assisted the Associate Deans for Faculty Affairs (Dr. David Bloom) and Student Programs (Dr. Rachel Glick) in general issues which pertained to faculty and students.

On August 16, 2011, Dr. Gordon accepted the position as the new Dean of the School of Health Professions and Studies at the University of Michigan-Flint where he will continue to pursue and advance his work.

Selected Extramural Invited Research Presentations:

"Growth factors and cell proliferation in human atherosclerosis." Alexis Carrel Conference on Transplant Arteriosclerosis, 1989.
"Cell proliferation in human coronary and carotid arteries." Altschul Conference on Arteriosclerosis, Saskatoon, Canada, 1989.
"Cell proliferation in human coronary arteries." The Lofland Conference on Arteriosclerosis, San Antonio, Texas, 1990.
"Growth factors and cell proliferation in human atherosclerosis." Lilly Corp., Indianapolis, IN, 1990.
"Cell proliferation in human transplant coronary arteries." The International Academy of Pathology, Chicago, IL, 1991.
"Cell proliferation in human atherosclerosis." The Department of Pathology, University of Michigan, Ann Arbor, MI, 1991.
"Cell proliferation in the coronary arteries of transplanted hearts." "The Blood Vessel Club," FASEB Meeting, Atlanta, GA, 1991.
"Cell proliferation in transplant arteriosclerosis." St. L ouis University, October 25, 1991.
"Cell proliferation in human arteries." The U.S. and Canadian Academy of Pathology, Atlanta, GA, 1992.
"Cell proliferation in human arterio-venous dialysis shunts." The "Blood Vessel Club," FASEB Meeting, Anaheim, CA , 1992.
"Cell proliferation in human atherosclerosis." Tufts University, Division of Cardiology, Boston, MA, 1992.
"Cell Proliferation and Collagen Gene Expression in Human Atherosclerosis." V ascular Medicine Seminar Series, Univ. of Michigan, May 3, 1994.
"Growth factors as inducers of neointimal hyperplasia." Special symposium on "Transplant Vascular Sclerosis" sponsored by Ohio State University College of Medicine, held in Bermuda, Feb. 2, 1995.
"Cell Proliferation and Collagen Gene Expression in Human Atherosclerosis." Univ. of Michigan to Cardiology (Grand Rounds), June 6, 1995.
"The growth of human atherosclerosis: Cell proliferation and collagen synthesis." U.S. and Canadian Association of Pathologists meeting (Society for Cardiovascular Pathology) Mar. 24, 1996; Washington D.C.
"Restenosis: A Pathologist"s view." Restenosis Summit, Cleveland, Ohio 1997.
"Cell proliferation and collagen synthesis in human atherosclerosis." Talk given to Cardiology Division, Univ. of Michigan, April 3, 1998.
"Growth of human atherosclerosis." Talk given at the 9th Annual R.W. Gunton Symposium on Cardiovascular Therapeutics, sponsored by the John P. Robarts Research Institute and presented at the University of Western Ontario, Canada (September. 11, 1998).
"The cellular growth of human atherosclerosis." Talk given to the Midwestern Vascular Surgical Society meeting in Chicago, Sept. 25, 1999.
"Growth factors, cell proliferation and collagen synthesis in human atherosclerosis." Talk given to the U.S.-Italy Joint Symposium on Genetic and Pharmacological Approaches in Vascular Biology, at the University of Milan, Italy (Dec. 2-4, 1999, sponsored by the National Institutes of Health, and the Institute of Pharmacological Sciences at the University of Milan).
"Atherosclerosis in African Americans: Path Prevention and Treatment." Ernest E. Just Symposium at Medical University of South Carolina, Feb. 14, 2003.

Other Invited Dean's Office Presentations:

“Diversity in Medical Education” Presentation to the Medical Educators Scholars Program, Univ. of Michigan, June 17, 2003
“Diversity in Medical Education” Presentation to the Medical Educators Scholars Program, Univ. of Michigan, May 11, 2004
“Visible and Invisible Aspects of Diversity” Presentation to Dept. of Pathology faculty and staff, May 11, 2005.
“Life after the Supreme Court: How the University of Michigan maintained their minority medical school enrollment.” Keynote talk at the national American Medical Association meeting (Minority Affairs Caucus), Chicago June 17, 2005.
“HPPI Sustaining Funding: The Story of our Univ. of Michigan HOPE Program.” Talk given at the Assoc. of American Medical Colleges’ Health Professionals Partnership Initiative last meeting, Wash. DC, Oct. 2, 2005.
“Role of Development in Funding Outreach Clinics and Other Special Projects: Thoughts on Obtaining External Funding.” Talk given at the Assoc. of American Medical Collages GSA-MAS national meeting in Philadelphia, April 4, 2006.
"Rock the Match: strengthening your ERAS application” Talk to medical students at the annual Student National Medical Association, New York, March 21, 2008.
"Addressing Diversity in Graduate Medical Education: Challenges and Perspectives" Panel discussion at the annual Association of American Medical Colleges meeting, San Antonio, Texas; Nov. 4, 2008
"Rock the Match: strengthening your ERAS application” Talk to medical students at Wayne State University, Detroit, Michigan, November 10, 2008.
"Rock the Match: strengthening your ERAS application” Talk to medical students at the regional Student National Medical Association, Cleveland, Ohio, November 14, 2008.
"Rock the Match: strengthening your ERAS application” Talk to medical students at the national Student National Medical Association, New Orleans, Louisiana, April 10, 2009.
“Rock the Match: How to beef up your application for Residency Programs.” Talk to medical students at the national Latino Medical Student Association meeting in Chicago, Illinois, Mar 6, 2010
“Community Benefits: What does it mean?” Talk to the Minority Health Research Program’s Community Advisory Board meeting in Ann Arbor, MI, Mar. 9, 2010.
“Rock the Match: How to beef up your application for Residency Programs.” Talk to medical students at the Student National Medical Association meeting in Chicago, Illinois, April 2, 2010
“Diversity: Threading the Needle Between Federal Affirmative Action Mandates and State Constitutional Amendments in Four States: Univ. of Michigan Medical School Experience. (panel discussion) Assoc. of American Medical Colleges meeting, New Orleans, Louisiana, March 24, 2011.”
“Rock the Match: How to beef up your application for Residency Programs.” Talk to medical students at the Latino Medical Student Association National Meeting at the Univ. of California, Irvine School of Medicine (April, 3, 2011)
“Rock the Match: How to beef up your application for Residency Programs.” Talk to medical students at the Student National Medical Association Meeting in Indianapolis, (April, 22, 2011)
Panelist for Kaplan Inc.’s, “Kaplan Live, Online Medical School Insider Event” (national/international webcast featuring various premedical advisors and admissions related personnel). New York City, May 23, 2011.
Panelist for the Univ. of Michigan Staff Mentoring and Coaching for Diversity Conference (Ann Arbor, MI), June 27, 2011.

Recent Scientific Publications (1995-Present):

....

Rekhter MD, Gordon D: Active proliferation of different cell types, including lymphocytes in human atherosclerotic plaques. Am. J. Pathol; 147:668-677, 1995.

Kolpakov V, Gordon D, Kulik TJ: Nitric oxide-generating compounds inhibit total protein and collagen synthesis in cultured vascular smooth muscle cells. Circ. Res; 76:305-309, 1995.

Pompili VJ, Gordon D, San H, Yang Z, Muller DWM, Nabel GJ, Nabel EG: Expression and function of a recombinant PDGF B gene in porcine arteries. Arterioscler. Thromb. Vasc. Biol; 15:2254-2264, 1995.

Kolpakov V, Rekhter MD, Gordon D, Wang WH, Kulik TJ: Effect of mechanical force on growth and matrix protein synthesis in the in vitro pulmonary artery: Analysis of the role of individual cell types. Circ Res; 77:823-831, 1995.

Thackray BD, Burns DH, Fergurson MS, Gordon D, Beach KW, Hatsukami T, Detmer PR, Primozich JF, Strandness DE. A new method of studying plaque morphology. Amer. J. of Cardiac Imaging; 9:149-156, 1995.

Kang S, Kim KJ, Griffiths CEM, Wong TY, Talwar HS, Fisher GJ, Gordon D, Hamilton TA, Ellis CN, Voorhees JJ. Topical tretinoin (retinoic acid) improves early stretch marks. Arch Dermatol; 132:519-526, 1996.

Schwartz SM, Gordon D, Mosca RS, Bove EL, Heidelberger KP, Kulik TJ. Collagen content in normal, pressure and pressure-volume overloaded developing human hearts. Am J Cardiol; 77:734-738, 1996.

Simari RD, San H, Rekhter M, Ohno T, Gordon D, Nabel GJ, Nabel EG. Regulation of cellular proliferation and intimal formation following balloon injury in atherosclerotic rabbit arteries. J Clin Invest; 98:225-235, 1996.

Yang ZY, Simari RD, Perkins ND, San H, Gordon D, Nabel GJ, Nabel EG. Role of the p21 cyclin-dependent kinase inhibitor in limiting intimal cell proliferation in response to arterial injury. Proc Natl Acad Sci USA; 93:7905-7910, 1996.

Sarkar R, Meinberg EG, Stanley JC, Gordon D, Webb RC. Nitric oxide reversibly inhibits the migration of cultured vascular smooth muscle cells. Circ Res; 78:225-230, 1996.

Rekhter M, Nicholls S, Ferguson M, Gordon D. Cell proliferation in human arteriovenous fistulas used for hemodialysis. Arteriosclerosis and Thrombosis; 13:609-617, 1996.

Nabel GJ, Yang ZY, Nabel EG, Bishop K, Marquet M, Felgner PL, Gordon D, Chang AE. Direct gene transfer for treatment of human cancer. Ann. N.Y. Acad. Sci; 772:227-31, 1996

Chang MW, Ohno T, Gordon D, Lu MM, Nabel GJ, Nabel EG, Leiden JM. Adenovirus-mediated transfer of the herpes simplex virus thymidine kinase gene inhibits vascular smooth muscle cell proliferation and neointima formation following balloon angioplasty of the rat carotid artery. Mol. Med; 1(2):172-81, 1996.

Fox BA, Woffendin C, Yang ZY, San H, Ranga U, Gordon D, Osterholzer J, Nabel GJ: Genetic modification of human peripheral blood lymphocytes with a transdominant negative form of Rev: safety and toxicity. Hum. Gene Ther; 6(8):997-1004, 1995.

Rekhter MD, O'Brien E, Shah N, Schwartz SM, Si mpson JB, Gordon D: The importance of thrombus organization and stellate cell phenotype in collagen I gene expression in human, coronary atherosclerotic and restenotic lesions. Cardiovascular Research; 32:496-502, 1996.

Nabel GJ, Gordon D, Bishop DK, Nickoloff BJ, Yang ZY, Aruga A, Cameron MJ, Nabel EG, Chang AE. Immune response in human melanoma after transfer of an allogeneic class I major histocompatibility complex gene with DNA-liposome complexes. Proc Natl Acad Sci USA; 93:15388-15393, 1996.

DeBruyne LA, Chang AE, Cameron MJ, Yang Z, Gordon D, Nabel EG, Nabel GJ, Bishop DK. Direct transfer of a foreign MHC gene into human melanoma alters T cell receptor V beta usage by tumor-infiltrating lymphocytes. Cancer Immunol. Immunother; 43(1): 49-58, 1996.

Welling TH, Davidson BL, Zelenock JA, Stanley JC, Gordon D, Roessler BJ, Messina LM. Systemic delivery of the interleukin-1 receptor antagonist protein using a new strategy of direct adenoviral-mediated gene transfer to skeletal muscle capillary endothelium in the isolated rat hindlimb. Hum. Gene Ther; 7(15):1795-802, 1996.

Stephan DJ, Yang ZY, San H, Simari RD, Wheeler CJ, Felgner PL, Gordon D, Nabel GJ, Nabel EG. A new cationic liposome DNA complex enhances the efficiency of arterial gene transfer in vivo. Hum. Gene Ther; 7(15):1803-12, 1996.

Isik FF, Coughlin SR, Nelken NA, Clowes AW, Gordon D. JE gene expression in an animal model of acute arterial graft rejection. J. Surg. Res; 60(1):224-31, 1996.

Muller DW, Gordon D, Topol EJ, Levy RJ, Golomb G. Sustained-release local hirulog therapy decreases early thrombosis but not neointimal thickening after arterial stenting. Am. Heart J; 131(2):211-8, 1996.

Sarkar R, Gordon D, Stanley JC, Web RC. Cell cycle effects of nitric oxide on vascular smooth muscle cells. Am. J. Physiol. 272:10050-10057, 1997.

Sarkar R, Gordon D, Stanley JC, Webb RC. Dual cell cycle-specific mechanisms mediate the antimitogenic effects of nitric oxide in vascular smooth muscle cells. J. Hypertens; 15(3):275-283, 1997.

Arai H, Gordon D, Nabel EG, Nabel GJ. Gene transfer of Fas ligand induces tumor regression in vivo. Proc. Natl. Acad. Sci. USA; 94(25):13862-7, 1997.

Stephan D, San H, Gordon D, Nabel GJ, Nabel EG. [Gene transfer of interferon beta inhibits vascular smooth muscle cell proliferation in vitro and in animal model of arterial injury.] Arch. Mal. Coeur. Vaiss; 90(8):1121-5, 1997.

Stephan D, San H, Yang ZY, Gordon D, Goelz S, Nabel GJ, Nabel EG. Inhibition of vascular smooth muscle cell proliferation and intimal hyperplasia by gene transfer of beta-interferon. Mol. Med; 3(9):593-9, 1997.

Lin H, Gastman BR, Wei RQ, Kunkel SL, Gordon D, Bolling SF. Phase-directed therapy and cardiac xenograft survival. J. Surg. Res; 72(1):84-8, 1997.

Jejurikar SS, Welling TH, Zelenock JA, Gordon D, Burkel WE, Carlson BM, Messina LM. Induction of angiogenesis by lidocaine and basic fibroblast growth factor: a model for in vivo retroviral-mediated gene therapy. J. Surg. Res; 67(2):137-46, 1997.

Hatsukami TS, Ferguson MS, Beach KW, Gordon D, Detmer P, Burns D, Alpers C, Strandness DE Jr. Carotid plaque morphology and clinical events. Stroke; 28(1):95-100, 1997.

Lupinetti-FM; Kneebone JM, Rekhter MD, Brockbank KG, Gordon D. Procollagen production in fresh and cryopreserved aortic valve grafts. J. Thorac. Cardiovasc. Surg; 113(1):102-7, 1997.

Tanner FC, Yang Z, Duckers E, Gordon D , Nabel GJ, Nabel EG: Expression of cyclin-dependent kinase inhibitors in vascular disease. Circ. Res. 82:396-403, 1998.

Rekhter MD, Simari RD, Work C, Nabel EG, Gordon D. Gene transfer into normal and atherosclerotic human blood vessels. Circ Res; 82:1243-1252, 1998.

Rekhter MD, Shah N, Simari RD, Work C, Kim J-S, Nabel GJ, Gordon D. Graft permeabilization facilitates gene therapy of transplant arteriosclerosis in rabbit model. Circulation; 98(13): 1335-41, 1998.

Rekhter MD, Hicks GW, Brammer DW, Work CW, Kim JS, Gordon D, Keiser JA, Ryan MJ: Animal model that mimics atherosclerotic plaque rupture. Circ Res, 83(7): 705-13, 1998.

Orekhov AN, Andreeva ER, Mikhailova IA, Gordon D: Cell proliferation in normal and atherosclerotic human aorta: proliferative splash in lipid-rich lesions. Atherosclerosis; Jul; 139(1): 41-8, 1998.

Andreeva ER, Pugach IM, Gordon D, Orekhov AN: Continuous subendothelial network formed by pericyte-like cells in human vascular bed. Tissue and Cell; Feb; 30(1): 127-35, 1998.

Ryan, MJ, Emig LL, Hicks GW, Ramharack R, Brammer DW, Gordon D, Auerbach BJ, Keiser JA: Influence of lipoprotein(a) plasma concentration on neointimal growth in a monkey model of vascular injury. Atherosclerosis 139:137-145, 1999.

Kornowski R, Leon MB, Fuchs S, Vodovotz Y, Flynn MA, Gordon D, Pierre A, Kovesdi I, Keiser JA, Epstein SE: Electromagnetic-guidance for catheter-based trans-endocardial injection: a platform for intramyocardial angiogenesis therapy. J. Am. Coll. Cardiol. 35(4):1031-1039, 2000.

Flynn MA, Vodovotz Y, Kornowski R, Epstein S, Gordon D, Keiser JA: Use of fluorescent microspheres to localize in vivo gene transfer injection sites. BioTechniques, 28(3):470-476, 2000.

Song Y, Ford JW, Gordon D, Shanley CJ: Regulation of lysyl oxidase by interferon- in rat aortic smooth muscle cells. Arterioscler. Thromb. Vasc. Biol. 20: 982-988, 2000.

Sjöland H, Eitzman DT, Gordon D, Westrick R, Nabel EG, Ginsburg D: Atherosclerosis progression in LDL receptor-deficient and apolipoprotein E-deficient mice is independent of genetic alterations in plasminogen activator inhibitor-1. Arterioscler. Thromb. Vasc. Biol; 20(3):846-52, 2000.

Wang H, Gordon D, Olszewski B, Song YL, Kovesdi I, Keiser JA: Rat sponge implant model: A new system for evaluating angiogenic gene transfer. Int. J. Mol. Med; 6(6):645-653, 2000.

Wang H. Liu C. Song Y. Gordon D. Alavi MZ. Moore S: Expression of metalloproteinases and its inhibitor in later stage of rabbit neointima development. International Journal of Molecular Medicine. 7(1):105-12, 2001

Perrin LA, June JE, Rosebury W, Robertson A, Kovesdi I, Bruder JT, Kessler PD, Keiser, JA, Gordon D: Increased revascularization efficacy after administration of an adenovirus encoding VEGF121. Gene Therapy 11:512-521, 2004.

Wang H, Keiser JA, Olszewski B, Brammer D, Gordon D: Dose-dependent neovascularization-promoting effect of adenovirus vector CI-1023 in a rat hindlimb ischaemic model. Basic & Clinical Pharmacology & Toxicology. 95(2):76-80, 2004 Aug

Wang H. Keiser JA. Olszewski B. Rosebury W. Robertson A. Kovesdi I. Gordon D: Delayed angiogenesis in aging rats and therapeutic effect of adenoviral gene transfer of VEGF. International Journal of Molecular Medicine. 13(4):581-7, 2004 Apr.

Miller DL, Li P, Gordon D, Armstrong, WF: Histological characterization of micro-lesions induced by myocardial contrast echocardiography. Echocardiography 22(1):25-34, 2005.

Miller DL, Li P., Dou C., Gordon D., Edwards C. A. and Armstrong, W. F.: Influence of Contrast Agent Dose and Ultrasound Exposure on Cardiomyocyte Injury Induced by Myocardial Contrast Echocardiography in Rats. Radiology 2005;237:137-143

Shen Y, Bodary PF, Vargas FB, Homeister JW, Gordon D, Ostenso KA, Shayman JA, and Eitzman DT: -Galactosidase A deficiency leads to increased tissue fibrin deposition and thrombosis in mice homozygous for the Factor V Leiden mutation.” Stroke 2006 37: 1106 – 1108

Miller DL, Li P, Dou C, Armstrong WF, Gordon D. Evans blue staining of cardiomyocytes induced by myocardial contrast echocardiography in rats: evidence for necrosis instead of apoptosis. Ultrasound Med Biol. 2007; 33(12):1988-96.

Gualano SK. Bolling SF. Gordon D. Wilson A. Bach DS.: High prevalence of false chordae tendinae in patients without left ventricular tachycardia. Pacing & Clinical Electrophysiology, 2007, Suppl. 30, 1:S156-159

Hoashi T, Florentine MS, Gordon D, Ohye RG: Cardiac papillary fibroelastoma presenting as chorea in childhood. Pediatr. Cardiol. 2009;30:995-7

Faust SM. Lu G, Marini BL, Zou W, Gordon D, Iwakura Y, Yasmina Laouar Y, and Bishop DK: Role of T Cell Transforming Growth Factor Beta Signaling and IL-17 in Allograft Acceptancee and Fibrosis Associated with Chronic Rejection" J. Immunol. 2009;183:7297-7306

Xu Z, Owens G, MD, Gordon D, Cain C, Ludomirsky A: Noninvasive creation of an atrial septal defect by histotrypsy in a canine model. Circulation 2010, 121:742-749

Bhavsar J, Gordon D, Shea M: Listeria myocarditis with an atypical intracavitary vegetation/thrombus. Heart 2010, 96:1637. [case report]

Chapters in Books and Invited Reviews:

Gordon D and Schwartz, SM: “Arterial smooth muscle differentiation”, in: JH Campbell and GR Campbell (eds.). In: Vascular Smooth Muscle in Tissue Culture, 1987.

Wilcox, JN, Schwartz, SM and Gordon D: “Local production of PDGF in the human atherosclerotic plaque”, in: Habenicht, Springer-Verlag and Heidelberg (eds.), In: Growth Factors, Differentiation Factors and Cytokines, 1990.

Gordon D: “Cell proliferation in human arteries”. Cardiovascular Pathology, 1992.

Nabel GJ, Nabel EG, Yang Z, Fox BA, Plautz GE, Gao X, Huang L, Shu S, Gordon D, Chang AE: “Molecular genetic interventions for cancer.” Cold Spring Harbor Symposia on Quantitative Biology. Vol LIX:699-707, 1994.

Gordon D and Rekhter MD. “Cell proliferation and collagen gene expression in human intimal hyperplasia”. In: Dorbin (ed), Intimal Hyperplasia, 1994.

Gordon D and Nable EG: “Growth factors as inducers of neointimal hyperplasia”. In: Orosz, Sedmak and Ferguson (eds.), In: Transplant Vascular Sclerosis, 1995.

Kohler T and Gordon D. “Cerebrovascular atherosclerosis”. In: Zierler (ed), Surgical Management of Cerebrovascular Disease, 1995.

Gordon D. “Human carotid artery atherosclerosis”. In: Ernst and Stanley (eds), Current Therapy in Vascular Surgery, 1995.

Gordon D. “Transplant Arteriosclerosis”. In: Ross and Topol (eds). Atherosclerosis and Coronary Artery Disease, 1996.

Gordon D., Rekhter MD: “The growth of human atherosclerosis: Cell proliferation and collagen synthesis.” Cardiovasc. Pathol. 6:103-116, 1997.

Gordon D, Song Y: “The Pathology of Human Carotid Restenosis.” In Ernst and Stanley (eds), Current Therapy in Vascular Surgery, 1999 in press.

Gordon D. “Transplant Arteriosclerosis” (Ch. 43, pp. 623-635) in Atherothrombosis and coronary Artery Disease ed. Fuster, Topol, and Nabel. Copyright 2005 by Lippincott Williams & Wilkins.